Zobrazeno 1 - 10
of 450
pro vyhledávání: '"123I - MIBG"'
Publikováno v:
South African Journal of Oncology, Vol 7, Iss 0, Pp e1-e6 (2023)
Background: 123I-Metaiodobenzylguanidine ([123I]mIBG) is the agent of choice to assess for presence of metastases and therapy response in patients with neuroblastoma. Aim: To assess [123I]mIBG scan results and outcome in patients with stage 4 neurob
Externí odkaz:
https://doaj.org/article/90cba5a81c24408688371bce78baf36f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alexandra Oudot, Alan Courteau, Mélanie Guillemin, Jean-Marc Vrigneaud, Paul Michael Walker, François Brunotte, Alexandre Cochet, Bertrand Collin
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background During anthracycline treatment of cancer, there is a lack for biomarkers of cardiotoxicity besides the cardiac dysfunction. The objective of the present study was to compare [18F]FDG and [123I]MIBG (metaiodobenzylguanidine) in a l
Externí odkaz:
https://doaj.org/article/ac1a22d1644d45eb8e547aaa06d27e52
Autor:
Masato Kobayashi, Asuka Mizutani, Yuka Muranaka, Kodai Nishi, Hisakazu Komori, Ryuichi Nishii, Naoto Shikano, Takeo Nakanishi, Ikumi Tamai, Keiichi Kawai
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 61 (2021)
Gastrointestinal tract absorption of cationic anticancer drugs and medicines was estimated using whole-body imaging following oral [123I]MIBG administration. [123I]MIBG was added to cultures of human embryonic kidney (HEK)293 cells expressing human o
Externí odkaz:
https://doaj.org/article/bae6afbbab2244dab82add208d3d30cd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yasushi Sakata, Takahisa Yamada, Yoshio Furukawa, Tsutomu Kawai, Kunpei Ueda, Takanari Kimura, Masatake Fukunami, Atsushi Kikuchi, Masato Kawasaki, Jun Nakamura, Masahiro Seo, Masatsugu Kawahira, Kiyomi Kayama, Tetsuya Watanabe, Shunsuke Tamaki, Takashi Morita, Daisuke Sakamoto
Publikováno v:
JACC: Cardiovascular Imaging. 15:655-668
Objectives The authors sought to elucidate the prognostic value of cardiac sympathetic nerve dysfunction as evaluated using iodine-123-labeled metaiodobenzylguanidine (123I-MIBG) single-ph...
Autor:
Takeshi Kamitani, Yuhki Koga, Yoshiyuki Kitamura, Yasuhiro Maruoka, Masayuki Sasaki, Naonori Kawakubo, Takuro Isoda, Kousei Ishigami, Shingo Baba, Toshiharu Matsuura
Publikováno v:
Annals of Nuclear Medicine
Objective 123I metaiodobenzylguanidine (MIBG) scintigraphy is a useful tool for the diagnosis of neuroblastoma (NB). MIBG uptake is correlated with norepinephrine transporter expression; hence, it is expected that high-MIBG tumors would be more highl
Autor:
Akihiro Nishie, Takuro Isoda, Masayuki Sasaki, Kousei Ishigami, Yoshiyuki Kitamura, Yasuhiro Maruoka, Shingo Baba
Publikováno v:
Annals of Nuclear Medicine. 36:95-102
OBJECTIVE 123I metaiodobenzylguanidine (MIBG) scintigraphy is a useful tool for the diagnosis of pheochromocytomas (PHEOs), but some PHEOs are difficult to differentiate from cortical adenoma (CA) or normal adrenal uptake by visual evaluation alone.
Autor:
Dorra Ben-Sellem, Naima Ben-Rejeb
Publikováno v:
Chinese Journal of Academic Radiology. 5:29-36
Autor:
Alexandre Cochet, Bertrand Collin, Mélanie Guillemin, Alexandra Oudot, Jean-Marc Vrigneaud, François Brunotte, Paul Walker, Alan Courteau
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Background During anthracycline treatment of cancer, there is a lack for biomarkers of cardiotoxicity besides the cardiac dysfunction. The objective of the present study was to compare [18F]FDG and [123I]MIBG (metaiodobenzylguanidine) in a longitudin